pages:
-
A Randomized Phase II Clinical Trial of L-Citrulline to Improve Asthma Control in Obese Late Onset Asthma
-
A Randomized Phase II clinical trial assessing the Efficacy and Safety of
MK-3475 (pembrolizumab) in combination with carboplatin and gemcitabine in
patients with metastatic triple negative breast cancer
-
A Randomized Phase II Study Evaluating Pembrolizumab vs Topotecan in the Second-line Treatment of Patients with Small Cell Lung Cancer
-
A Randomized Phase II Study Evaluating Pembrolizumab vs Topotecan in the Second-line Treatment of Patients with Small Cell Lung Cancer
-
A randomized phase II study of adjuvant Trastuzumab emtansine (T-DM1) vs Paclitaxel in combination with Trastuzumab for stage I HER2-positive breast cancer (ATEMPT Trial)
-
A Randomized Phase II Study of Nivolumab and Temozolomide vs Temozolomide alone in newly diagnosed elderly patients with Glioblastoma (NUTMEG)
-
A RANDOMIZED PHASE II STUDY OF PREOPERATIVE CISPLATIN VS PACLITAXEL IN PATIENTS WITH TRIPLE NEGATIVE BREAST CANCER WITHOUT GERMLINE BRCA MUTATIONS: EVALUATING THE HOMOLOGOUS RECOMBINATION DEFICIENCY (HRB) BIOMARKER
-
A randomized phase II trial of adjuvant trastuzumab emtansine (T-DM1) followed by subcutaneous trastuzumab versus paclitaxel in combination with subcutaneous trastuzumab for Stage I HER2-positive breast cancer (ATEMPT 2.0)
-
A Randomized Phase IIB Open Label Study of Nivolumab in combination with Ipilimumab versus Bevacizumab in Adult Subjects with Recurrent Glioblastoma (GBM)
-
A Randomized Trial of An Integrated Clinical-Community Partnership Model For Childhood Obesity Treatment
Research Grant
-
A Randomized Trial of Bilateral Lateral Rectus Recession versus Unilateral Lateral Rectus Recession with Medial Rectus Resection for Intermittent Exotropia
-
A randomized trial of CT fluoroscopy-guided targeted autologous blood and fibrin glue patching for treatment of imaging-confirmed CSF leaks in patients with spontaneous intracranial hypotension.
Research Grant
-
A Randomized Trial of Financial Incentives for Maintenance of Weight Loss
Research Grant
-
A Randomized Trial of Fistula vs. Graft Arteriovenous Vascular Access in Older Adults with End-Stage Kidney Disease on Hemodialysis: The AV ACCESS Trial
-
A Randomized Trial of Headache Management Programs
Research Grant
-
A RANDOMIZED TRIAL OF LOW-DOSE BEVACIZUMAB VERSUS LASER FOR TYPE 1 RETINOPATHY OF PREMATURITY (ROP3)
-
A Randomized Trial of Scalable, Interactive Tool to Support Surrogate Decision Makers of Elderly Critically Ill pAtients
-
A Randomized Trial of Two Promising Interventions for Students with Attention Problems
Research Grant
-
A Randomized Trial to Evaluate Sequential vs Simultaneous Spectacles plus Patching for Amblyopia in Children 3 to <13 Years Old (ATS22)
Research Grant
-
A Randomized, Blinded, Placebo-controlled, Phase 2 Study of INBRX-109 in Unresectable or Metastatic Conventional Chondrosarcoma
-
A Randomized, Controlled Pilot Study of an Intervention for Medication Adherence
Research Grant
-
A RANDOMIZED, CONTROLLED, DOUBLE-MASKED, CROSSOVER CLINICAL TRIAL DESIGNED TO EVALUATE THE SAFETY AND EXPLORATORY EFFICACY OF 1.0 mg LUMINATE® (ALG-1001) AS A TREATMENT FOR NON-EXUDATIVE MACULAR DEGENERATION
Research Grant
-
A Randomized, Controlled, Multicenter Trial of Percutaneous Peripheral Nerve Stimulation (PNS) for the Treatment of Back Pain
-
A randomized, controlled, parallel-group, intervention study to assess at-home, game-based digital therapy for treating pediatric participants ages 8 to 12 years old with Attention Deficit Hyperactivity Disorder (ADHD)
-
A Randomized, Controlled, Phase 3 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Melphalan/HDS Treatment in Patients with Hepatic-Dominant Ocular Melanoma
-
A Randomized, Dbl-Blind, Placebo-Controlled, Parallel-Grp, Multictr, Ph 3 Study-Safety, Tolerability, and Efficacy of CMX001 for the Prevention of Cytomegalovirus (CMV) Infection in CMV-seropositive (R+) Hematopoietic Stem Cell Transplant Recipients
-
A Randomized, Double blind, Active Control Study of the Safety and Efficacy of PRX-102 compared to Agalsidase Beta on Renal Function in Patients with Fabry Disease Previously Treated With Agalsidase Beta
-
A randomized, double blind, parallel-group, placebo controlled study to evaluate the efficacy and safety of IBP-9414 in premature infants 500-1500 grams birth weight in the prevention of necrotizing enterocolitis ¿ The Connection study
-
A Randomized, Double Masked, Active Controlled Phase 2 Study of the Efficacy, Safety, and Tolerability of Repeated Doses of Intravitreal REGN910-3 in Patients with Diabetic Macular Edema
Research Grant
-
A Randomized, Double Masked, Active Controlled Phase 2 Study of the Efficacy, Safety, and Tolerability of Repeated Doses of Intravitreal REGN910-3 in Patients with Neovascular Age-Related Macular Degeneration
Research Grant
pages: